FDA Approved Products

6,646 products with lifecycle intelligence, competitive pressure scores, and patent timelines.

Type:AllNDABLAANDA
Lifecycle:GrowthPeakLOE ApproachingPost-LOELaunchPre-Launch
Sort:Approval DateNameCompetitive Pressure↓
PREVANTICS MAXI SWABSTICK
chlorhexidine gluconate and isopropyl alcohol
LOE Approaching
TOPICAL · SWAB
2005
NDA
30/100
PREVANTICS SWAB
chlorhexidine gluconate and isopropyl alcohol
LOE Approaching
TOPICAL · SWAB
2005
NDA
30/100
PREVANTICS SWABSTICK
chlorhexidine gluconate and isopropyl alcohol
LOE Approaching
TOPICAL · SWAB
2005
NDA
30/100
PREVEN EMERGENCY CONTRACEPTIVE KIT
ethinyl estradiol; levonorgestrel
LOE Approaching
TevaTeva
ORAL · TABLET
1998
NDA
30/100
PREVPAC (COPACKAGED)
amoxicillin; clarithromycin; lansoprazole
LOE Approaching
TakedaTakeda
ORAL · CAPSULE, TABLET, CAPSULE, DELAYED REL PELLETS
1997
SMNDA
30/100
PREZCOBIX
darunavir and cobicistat
Launch
J&
Johnson & Johnson
ORAL · TABLET, FOR SUSPENSION
2026
SMNDA
30/100
PRIALT
ziconotide acetate
LOE Approaching
TerSera TherapeuticsTerSera Therapeutics
INTRATHECAL · INJECTABLE
2004
NDA
30/100
PRIFTIN
rifapentine
LOE Approaching
SanofiSanofi
ORAL · TABLET
latent tuberculosis infection (LTBI) caused by Molder for the treatment of active pulmonary tuberculosis (TB) caused by Mycobacterium tuberculosis+2
1998
NDA
30/100
PRILOSEC
omeprazole
LOE Approaching
AstraZenecaAstraZeneca
ORAL · CAPSULE, DELAYED REL PELLETS
1989
SMNDA
30/100
PRILOSEC
omeprazole magnesium
LOE Approaching
R-Pharm USR-Pharm US
ORAL · FOR SUSPENSION, DELAYED RELEASE
heartburnother symptoms associated with GERD for up to 4 weeks in patients 1 year of age+1
2008
NDA
30/100
PRILOSEC OTC
omeprazole magnesium
LOE Approaching
AstraZenecaAstraZeneca
ORAL · TABLET, DELAYED RELEASE
2003
NDA
30/100
PRIMACOR
milrinone lactate
LOE Approaching
SanofiSanofi
INJECTION · INJECTABLE
1987
NDA
30/100
PRIMACOR IN DEXTROSE 5% IN PLASTIC CONTAINER
milrinone lactate
LOE Approaching
SanofiSanofi
INJECTION · INJECTABLE
1994
NDA
30/100
PRIMAQUINE
primaquine phosphate
LOE Approaching
SanofiSanofi
ORAL · TABLET
1952
NDA
30/100
PRIMATENE MIST
epinephrine
LOE Approaching
PfizerPfizer
INHALATION · AEROSOL, METERED
1967
NDA
30/100
PRIMAXIN
cilastatin sodium; imipenem
LOE Approaching
M&
Merck & Co.
INTRAMUSCULAR · POWDER
1990
NDA
30/100
PRIMAXIN
imipenem and cilastatin sodium
LOE Approaching
M&
Merck & Co.
INTRAVENOUS · POWDER
1985
NDA
30/100
PRIMSOL
trimethoprim hydrochloride
LOE Approaching
TerSera TherapeuticsTerSera Therapeutics
ORAL · SOLUTION
1995
NDA
30/100
PRIMSOL
trimethoprim hydrochloride
LOE Approaching
TerSera TherapeuticsTerSera Therapeutics
ORAL · SOLUTION
2000
NDA
30/100
PRINIVIL
lisinopril
LOE Approaching
M&
Merck & Co.
ORAL · TABLET
1987
SMNDA
30/100
PRINZIDE
hydrochlorothiazide; lisinopril
LOE Approaching
M&
Merck & Co.
ORAL · TABLET
1989
SMNDA
30/100
PRISCOLINE
tolazoline hydrochloride
LOE Approaching
NovartisNovartis
INJECTION · INJECTABLE
1948
NDA
30/100
PRISMASOL B22GK 2/0 IN PLASTIC CONTAINER
magnesium chloride, dextrose anhydrous, lactic acid, sodium chloride, sodium bicarbonate, and potassium chloride
LOE Approaching
VantiveVantive
INJECTION · INJECTABLE
2006
NDA
30/100
PRISMASOL B22GK 2/2.5 IN PLASTIC CONTAINER
magnesium chloride, dextrose anhydrous, lactic acid, sodium chloride, sodium bicarbonate, and potassium chloride
LOE Approaching
VantiveVantive
INJECTION · INJECTABLE
2006
NDA
30/100
← PreviousPage 145 of 277Next →